Mark Hopman insider trades
Open-market stock purchases and sales by Mark Hopman, Chief Commercial Officer at Beta Bionics, Inc, from SEC Form 4 filings since Jan 29, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 16, 2026 | BBNX Beta Bionics, Inc | Sold | $620K |
| Sep 14, 2026 | BBNX Beta Bionics, Inc | Sold | $12K |
| Sep 9, 2026 | BBNX Beta Bionics, Inc | Sold | $681K |
| Sep 9, 2026 | BBNX Beta Bionics, Inc | Sold | $665K |
| Sep 2, 2026 | BBNX Beta Bionics, Inc | Sold | $102K |
| Jun 24, 2026 | BBNX Beta Bionics, Inc | Sold | $18.9K |
| Jun 4, 2026 | BBNX Beta Bionics, Inc | Sold | $3.4K |
| Jun 2, 2026 | BBNX Beta Bionics, Inc | Sold | $67.2K |
| Mar 4, 2026 | BBNX Beta Bionics, Inc | Sold | $4.1K |
| Mar 2, 2026 | BBNX Beta Bionics, Inc | Sold | $10.3K |
| Feb 27, 2026 | BBNX Beta Bionics, Inc | Bought (not open market) | — |
| Feb 27, 2026 | BBNX Beta Bionics, Inc | Bought (not open market) | — |
| Feb 27, 2026 | BBNX Beta Bionics, Inc | Bought (not open market) | — |
| Dec 4, 2025 | BBNX Beta Bionics, Inc | Sold | $63.2K |
| Dec 2, 2025 | BBNX Beta Bionics, Inc | Sold | $25.1K |
Companies traded
- BBNX Beta Bionics, Inc: 19 sales, last Sep 16, 2026